TerminatedNot Applicable

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Stopped: Unable to recruit due to COVID limitations / Funding Unavailable

United States319 participantsStarted 2015-06-01

Plain-language summary

This clinical trial studies an informed decision making intervention of screening for prostate cancer in predominantly African American participants. It also evaluates participants' knowledge about prostate cancer screening and to improve understanding. Using decision aids such as culturally sensitive written material, verbal information, and videos to educate patients about screening may increase patient participation and knowledge. This may increase confidence in participants' decisions. Raising awareness about prostate cancer in the communities may increase the participants' willingness to be screened for prostate cancer once they have learned about it.

Who can participate

Age range19 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men over the age of 18 will be asked to participate in the educational component of the program; men over the age of 40 will be offered the screening component after the educational portion of the event; participants over age of 40 will have the opportunity to make an informed decision in regards to prostate cancer screening based on this information and the educational material; American Cancer Society (ACS) guidelines recommend having a discussion about screening in men who have an expected mortality of greater than 10 years; data on comorbidities and 10-year mortalities will be collected on every participant using the University of California at San Francisco (UCSF) mortality index * Educational component: men over the age of 18 * Screening component: men over age 40 Exclusion Criteria: * Known personal history of prostate cancer * Active malignancy, metastatic disease, or anyone undergoing treatment for malignancy

What they're measuring

Proportion of participants over age 18 that demonstrate improved knowledge about prostate cancer screening

Timeframe: Up to 1 year

Proportion of participants over age 40 who find this education and screening model helpful in making an informed decision about prostate cancer screening as measured by the satisfaction survey questions

Timeframe: Up to 1 year

Trial details

NCT IDNCT02419846

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10

View on ClinicalTrials.gov More Prostate Carcinoma trials

Plain-language summary

Who can participate

Age range19 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Proportion of participants over age 18 that demonstrate improved knowledge about prostate cancer screening

Timeframe: Up to 1 year